NCT04438798

Brief Summary

Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) using high flow oxygen therapy for preoxygenation and oxygen supplementation during apnoea has shown promising results

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 19, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

August 18, 2020

Status Verified

August 1, 2020

Enrollment Period

3 months

First QC Date

June 17, 2020

Last Update Submit

August 16, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • measure the time of safe apnea

    The apnea time will start from the onset of cessation of breathing as evidenced by a flat line in the capnogram with the absence of chest movements

    10 minutes after induction

Study Arms (2)

face mask group

PLACEBO COMPARATOR

Pregnant females will be preoxygenated with 100% oxygen using a tight-fitting face mask at a rate of 6 L/min for 3 min with end-tidal gas monitoring.

Other: F Group

THRIVE group

ACTIVE COMPARATOR

High-flow humidified oxygen warmed to 37°C will be delivered through nasal cannula at the rate of 30 L/ min for 30 seconds then 50 liters per minute for a further 150 seconds.

Other: H Group

Interventions

F GroupOTHER

In Group F, pregnant females will be preoxygenated with 100% oxygen using a tight-fitting face mask at a rate of 6 L/min for 3 min with end-tidal gas monitoring.

Also known as: face mask
face mask group
H GroupOTHER

In Group H, high-flow humidified oxygen warmed to 37°C will be delivered through nasal cannula at the rate of 30 L/ min for 30 seconds then 50 liters per minute for a further 150 seconds.

Also known as: THRIVE
THRIVE group

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • pregnant females
  • Of American Society of Anesthesiologists (ASA) physical Status I and II
  • For elective cesarean section under general anesthesia

You may not qualify if:

  • with room air saturation of \<98%
  • anticipated difficult airway
  • anticipated obstetric risk factor or precious baby
  • chronic obstructive pulmonary disease
  • thyrotoxicosis
  • pheochromocytoma
  • hyperkalaemia
  • significant cardiac illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehab Abd Elraof Abd Elaziz

Alexandria, 000000, Egypt

RECRUITING

Related Publications (1)

  • Mir F, Patel A, Iqbal R, Cecconi M, Nouraei SA. A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia. 2017 Apr;72(4):439-443. doi: 10.1111/anae.13799. Epub 2016 Dec 30.

    PMID: 28035669BACKGROUND

MeSH Terms

Conditions

Hypoxia, BrainMaternal Death

Interventions

MasksNicotine

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsParental DeathDeathPathologic Processes

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and AgricultureSolanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Rehab A. Abd Elaziz, Ass.Prof.

    Alexandria University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rehab A. Abd Elaziz, Ass. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant Professor of Anesthesia

Study Record Dates

First Submitted

June 17, 2020

First Posted

June 19, 2020

Study Start

July 1, 2020

Primary Completion

October 1, 2020

Study Completion

November 1, 2020

Last Updated

August 18, 2020

Record last verified: 2020-08

Locations